World's Best Scientists 2026 revealed!
Journal of Psychopharmacology
H-index 41

Journal of Psychopharmacology

0269-8811

Published by: SAGE

https://journals.sagepub.com/home/jop

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Psychology 108 178 240 32
Medicine 830 131 158 26

Additional Metrics

Number of Best Scientists*: 427
Documents by Best Scientists*: 414
Top 100 Ranked Scientists*: 8
SCIMAGO H-index: 143
SCIMAGO SJR: 1.708
Impact Factor: 5.5

Overview

Top Research Topics at Journal of Psychopharmacology?

The topics of Internal medicine, Psychiatry, Endocrinology, Pharmacology and Neuroscience are the focal point of discussions in Journal of Psychopharmacology. The research on Internal medicine featured in the journal combines topics in other fields like Antidepressant, Anesthesia and Placebo. The study on Placebo featured in the journal expounds on the topic of Crossover study in particular.

The study on Psychiatry presented in it intersects with the topics under Clinical psychology. The majority of Endocrinology studies presented zero in on Reuptake inhibitor. The studies on Pharmacology discussed can also contribute to research in the domains of Receptor and Antagonist.

The Neuroscience research dealing mostly with Cognition is the focus of Journal of Psychopharmacology. Journal of Psychopharmacology connects the study in Schizophrenia with the closely related area of Psychosis. Many of the studies tackled connect Antipsychotic with a similar field of study like Clozapine.

  • Internal medicine (26.26%)
  • Psychiatry (25.61%)
  • Endocrinology (18.69%)

What are the most cited papers published in the journal?

  • 5-HT and mechanisms of defence. (826 citations)
  • Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology (784 citations)
  • Conditioning factors in drug abuse: can they explain compulsion?: (583 citations)

Research areas of the most cited articles at Journal of Psychopharmacology:

The most cited publications mostly deal with topics like Psychiatry, Internal medicine, Endocrinology, Pharmacology and Neuroscience. The most cited papers tackle studies in Clinical psychology and the interrelated subject of Addiction and Psychotherapist to gain insights into Psychiatry. The subject of Placebo, which is connected to the field of Anesthesia, Randomized controlled trial and Tolerability, serves as the foundation of the Internal medicine research featured in the published articles.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Pharmacology
  • Disease

The previous edition focused in particular on these issues:

The journal facilitates discussions on Neuroscience, Pharmacology, Internal medicine, Psychiatry and Schizophrenia. In addition to Neuroscience research, the journal aims to explore topics under NMDA receptor, Receptor and Glutamatergic. Topics in Pharmacology were tackled in line with various other fields like Antidepressant, Dopamine and Ketamine.

It explores topics in Internal medicine which can be helpful for research in disciplines like Placebo, Endocrinology, Esketamine and Oncology. Psychiatry studies presented include Cannabis, Depression (differential diagnoses), Psychopharmacology, Major depressive disorder and Bipolar disorder. While Depression (differential diagnoses) is the focus of the journal, it also provided insights into the studies of Meta-analysis and Anxiety.

The most cited articles from the last journal are:

  • Ketamine: A tale of two enantiomers. (14 citations)
  • Pivotal mental states (10 citations)
  • Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice. (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Psychopharmacology (based on the number of publications) are:

  • David J. Nutt (194 papers) published 7 papers at the last edition, 5 more than at the previous edition,
  • Catherine J. Harmer (58 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Philip J. Cowen (51 papers) absent at the last edition,
  • Guy M. Goodwin (47 papers) absent at the last edition,
  • David Taylor (43 papers) published 2 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Psychopharmacology (based on the number of publications) are:

  • King's College London (215 papers) published 22 papers at the last edition, 12 more than at the previous edition,
  • University of Bristol (170 papers) published 2 papers at the last edition, 2 less than at the previous edition,
  • Imperial College London (133 papers) published 15 papers at the last edition, 10 more than at the previous edition,
  • University of Oxford (112 papers) published 4 papers at the last edition, 2 less than at the previous edition,
  • University College London (84 papers) published 9 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.36% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 31.25% were posted by at least one author from the top 10 institutions publishing in the journal. Another 4.17% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.58% of all publications and 50.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Becoming a Contributor to Journal of Psychopharmacology

If you are an aspiring researcher or academic scholar in fields related to psychopharmacology, becoming a contributor to this journal could significantly propel your career. Submitting your research to a high-citation rate journal increases visibility and establishes you as an authority in your field. But, how can you become a contributor?

First, you need to conduct high-quality research that aligns with the focal topics of the journal. These topics include Internal medicine, Psychiatry, Endocrinology, Pharmacology, and Neuroscience. Your research should provide innovative insights, critical analysis, or discover new aspects related to these fields.

Next, you need to prepare your manuscript according to the guidelines provided by the Journal of Psychopharmacology. This includes formatting, citation style, and submission process. It is crucial to adhere to these guidelines to increase the chances of your manuscript being accepted.

In addition, you might like to work at institutions recognized by the journal. For instance, working at institutions such as top research universities or medical facilities that are recognized by the journal could increase your chances of publication.

Moreover, collaborating with experienced authors who have already published in the journal also increases the chance of acceptance. They can provide useful tips and guidance about the journal's expectations and review process.

Lastly, keep in mind that persistence and resilience are key. Many researchers face rejection initially. Use this as an opportunity to improve your research and manuscript.

Getting published in journals like the Journal of Psychopharmacology is a significant milestone for many scientists and researchers. It takes time, effort, and patience but the rewards are worth it. Start your journey today! For researchers interested in a different but related field, figuring out how to become a forensic scientist in Wisconsin could provide a completely new perspective.

Top Publications

  • Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

    Unknown

    (2022)
    505 Citations
  • Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer:

    Gabrielle I Agin-Liebes;Tara Malone;Matthew M Yalch;Sarah E Mennenga

    (2020)
    337 Citations
  • Ketamine: A tale of two enantiomers.

    Luke A Jelen;Allan H Young;Allan H Young;James M Stone;James M Stone

    (2021)
    216 Citations
  • Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression:

    Lea J Mertens;Matthew B Wall;Matthew B Wall;Leor Roseman;Lysia Demetriou;Lysia Demetriou

    (2020)
    183 Citations
  • Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review

    (2022)
    147 Citations
  • Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.

    Alan K Davis;Alan K Davis;Frederick S Barrett;Sara So;Natalie Gukasyan

    (2021)
    122 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but not ready to pursue a full medical degree, online programs offer flexible alternatives. The cma to lpn bridge programs online provide a pathway for certified medical assistants aiming to advance their careers as licensed practical nurses, combining hands-on skills with academic knowledge.

Many students also consider foundational sciences like biology. Enrolling in online biology programs can prepare you for various medical or research careers by deepening your understanding of living systems.

If nursing is your goal, an online asn program offers a valuable route to becoming a registered nurse. These programs often emphasize clinical practice alongside theoretical coursework, leading directly to licensure eligibility.

Meanwhile, those with an interest in health and wellness may explore an online bachelor's in nutrition. This degree supports careers in dietetics, public health, and wellness coaching by focusing on food science and its impact on the human body.

Best Scientists Contributing to This Journal